Top Markets
Coin of the day
Science 37 Holdings, Inc. Science 37 Holdings, Inc.

Science 37 Holdings, Inc.

SNCE
Rank in Stocks #11780
Science 37 Holdings, Inc. specializes in providing innovative technology... Science 37 Holdings, Inc. specializes in providing innovative technology solutions to enable flexible and decentralized clinical trials. Their central platform facilitates modern, digital approaches to clinical research by bringing together all essential parties—including patients, trial investigators, nurses, coordinators, and sponsors—to streamline processes, centralize data generation, and standardize information. Furthermore, the platform integrates specialized networks of patient communities, telemedicine-enabled investigators, mobile nursing professionals, remote coordinators, and connected health devices, all vital for orchestrating adaptable clinical studies. Its highly configurable nature means it can support nearly any phase of a clinical study and a wide range of medical indications. Beyond its direct services, the company also licenses its proprietary, cloud-based technology platform to various life science institutions. Science 37 serves a diverse client base, including major and mid-sized pharmaceutical companies, Contract Research Organizations (CROs), academic institutions, and biotechnology firms. Established in 2014, Science 37 Holdings, Inc. is headquartered in Research Triangle Park, North Carolina.
Share Price
$5.75
Last synced: 2024-03-22
Market Cap
$659.57M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Science 37 Holdings, Inc. (SNCE)

Category

P/E ratio for Science 37 Holdings, Inc. (SNCE)
P/E ratio as of 2026 TTM: 0
According to Science 37 Holdings, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Science 37 Holdings, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.